ICI’s NOLVADEX (TAMOXIFEN) SHOULD BE INDICATED FOR ADVANCED MALE BREAST CANCER BUT NOT AS ADJUVANT THERAPY IN MEN, ONCOLOGICS ADVISORY CMTE. CONCLUDES